Search

everythinglearnresearchcommunity

for

Search:↓

The combination of minoxidil, microneedling, and PRP is more effective for hair growth than minoxidil alone.

The document concludes that accurate diagnosis of hair disorders is crucial and requires a range of diagnostic methods.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

The BASP classification is a detailed system for categorizing hair loss in both men and women, but it may be complex for beginners and not fully suitable for grading female hair loss.

The document explains how hair loss patterns in men and women, known as Androgenetic alopecia, are classified using the Hamilton-Norwood system for men and the Ludwig grade system for women.

The document explains how hair loss in men and women, known as Androgenetic alopecia, is categorized using the Hamilton-Norwood system for men and the Ludwig grade system for women.

Dr. Muhammad Ahmad created a simpler system to better describe male pattern hair loss.

Androgenetic alopecia in Nepalese men often starts around age 29, with a possible link to COVID-19 worsening the condition.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Men can report their own balding patterns well enough for large health studies.

MRI helps evaluate androgenetic alopecia severity.

Certain Prakruti types are more prone to early male pattern baldness.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

CEOs aged 50-69 have less significant hair loss than the general white male population.

CEOs aged 50-69 have less significant hair loss than the general white male population.

MNC-QQ cell therapy improved hair growth and quality of life in men with androgenic alopecia without adverse effects.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

Using a laser with minoxidil was more effective for hair loss than minoxidil alone.

Finasteride is effective and safe for long-term treatment of hair loss in Japanese men.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

New grading scale accurately measures hair loss severity and treatment effectiveness.

Early balding, premature graying, and hair thinning can predict heart disease in young Asian males.

Balding in men worsens with age.

Smoking is linked to more hair loss and premature graying compared to nonsmokers.

Women look young for their age due to larger lips, less sun damage, and genes that prevent gray hair and wrinkles.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.